Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
View Older Stories View More Recent Stories
-
Inflection Point Acquisition Corp. and Intuitive Machines, LLC Announce Closing of Business Combination; Intuitive Machines, Inc. to Trade on Nasdaq Under Ticker Symbols “LUNR” and “LUNRW”
-
Longboard Pharmaceuticals Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares in Public Offering of Common Stock
-
Cantor Fitzgerald Helping Oversee Tether's $39 Billion in Treasurys, Sources Say -- WSJ
-
enCore Energy Closes C$34.5m Public Offering
-
Electra Battery Materials (ELBM) Announces $51 Million Convertible Note Offering, Intention to Repurchase and Cancel Existing Convertible Notes
-
Electra Announces US$51 Million Convertible Note Offering, Intention to Repurchase and Cancel Existing Convertible Notes and Discussions With Respect to Potential Additional Sources of Funding
-
Longboard Pharmaceuticals (LBPH) prices 5m shares at $4
-
Longboard Pharmaceuticals Announces Pricing of Public Offering of Common Stock
-
Longboard Pharmaceuticals (LBPH) Announces Commencement of Public Offering of Common Stock
-
Longboard Pharmaceuticals Announces Commencement of Public Offering of Common Stock
-
Oppenheimer Announces Expansion of Investment Grade Fixed Income Sales Team
-
Eloro Resources Ltd. (TSX.V: ELO) (OTCQX: ELRRF) (FSE: P2QM) Announces Successful Capital Raising; Net Proceeds Will Be Destined Towards Ongoing Bolivian Mining Operations
-
DURECT Corp (DRRX) Announces $10 Million Registered Direct Offering of Common Stock and Warrants (earlier)
-
Cantor Fitzgerald Starts Outlook Therapeutics Incs. (OTLK) at Overweight
-
DURECT Corporation Announces $10 Million Registered Direct Offering of Common Stock and Warrants
-
Form SC 13G Tristar Acquisition I Filed by: CANTOR FITZGERALD SECURITIES
-
Roivant Sciences (ROIV) Prices Upsized 26.67M Share Offering at $7.50/sh
-
Roivant Sciences Announces Pricing of Upsized Public Offering of Common Shares
-
Roivant Sciences Announces Pricing of Upsized Public Offering of Common Shares
-
Today's most important initiations
-
Form 8-K Cantor Fitzgerald Income For: Jan 31
-
Roivant Sciences (ROIV) Announces Proposed $150M Share Offering
-
Roivant Sciences Announces Proposed Public Offering of Common Shares
-
Roivant Sciences Announces Proposed Public Offering of Common Shares
-
Vesta Taps Shimon Steinmetz as Chief Financial Officer
-
Pfizer falls as slowing demand for COVID-19 drugs weighs on outlook
-
Form SC 13G Appreciate Holdings, Filed by: CANTOR FITZGERALD & CO.
-
CymaBay Announces Closing of Public Offering of Common Stock and Pre-Funded Warrants, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Generac, Veru, Gap, and Singularity and Encourages Investors to Contact the Firm
-
Precigen Announces Closing of Public Offering of Common Stock
-
Village Farms (VFF) Prices 18.35M Share Offering at $1.35/sh
-
Village Farms International Announces Approximately US$25 Million Registered Direct Offering
-
Cantor Fitzgerald Initiates Coverage on Prenetics with "Overweight" Rating
-
Precigen Inc. (PGEN) Prices 42.86M Share Offering at $1.75/sh
-
Precigen Announces Pricing of $75.0 Million Public Offering of Common Stock
-
Precigen Inc. (PGEN) Announces Proposed $75.0 Million Public Offering of Common Stock
-
Precigen Announces Proposed $75.0 Million Public Offering of Common Stock
-
CymaBay Therapeutics (CBAY) Prices $75M Share and Warrant Offering at $7/sh
-
CymaBay Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants
-
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Generac, Veru, Gap, and Singularity and Encourages Investors to Contact the Firm
-
CymaBay Therapeutics (CBAY) Announces Proposed Public Offering of Common Stock, Pre-Funded Warrants
-
CymaBay Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
-
Pantheon Welcomes Four New Partners, Announces Global Promotions to Enhance Long-Term Growth Capabilities
-
Lilly shares slip after FDA rejects early Alzheimer's drug approval
-
Cohen & Company Capital Markets Continues Strong Growth Despite Tumultuous Capital Market Environment
-
Cantor Fitzgerald Announces the Sale of Rivertop Apartments in Nashville, Tennessee
-
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Generac, Veru, Gap, and Singularity and Encourages Investors to Contact the Firm
-
Form 424B3 Cantor Fitzgerald Income
-
Moderna (MRNA) stock up 7% after RSV vaccine candidate met targets, analysts positive
-
Davos 2023: Convert offices to homes to curb housing crisis-panel

